Bothig R, et al. Clinical characteristics of bladder cancer in patients with spinal cord injury: the experience from a single centre. Int Urol Nephrol. 2017;49(6):983–94.
Ho CH, et al. Chronic indwelling urinary catheter increase the risk of bladder cancer, even in patients without spinal cord injury. Medicine (Baltimore). 2015;94(43):e1736.
Article PubMed PubMed Central Google Scholar
Pannek J, Rademacher F, Wollner J. Clinical usefulness of urine cytology in the detection of bladder tumors in patients with neurogenic lower urinary tract dysfunction. Res Rep Urol. 2017;9:219–23.
PubMed PubMed Central Google Scholar
Ismail S, et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn. 2018;37(4):1386–95.
Biardeau X, et al. Risk of malignancy after augmentation cystoplasty: a systematic review. Neurourol Urodyn. 2016;35(6):675–82.
Husmann DA. Malignancy after gastrointestinal augmentation in childhood. Ther Adv Urol. 2009;1(1):5–11.
Article PubMed PubMed Central Google Scholar
Gui-Zhong L, Li-Bo M. Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord. 2017;55(4):341–5.
Article CAS PubMed Google Scholar
Welk B, et al. Bladder cancer in individuals with spinal cord injuries. Spinal Cord. 2013;51(7):516–21.
Article CAS PubMed Google Scholar
Michel F, et al. Incidence of bladder cancer in neuro-urological patients in France: a nationwide study. World J Urol. 2022;40(8):1921–7.
Husmann DA. Mortality following augmentation cystoplasty: a transitional urologist's viewpoint. J Pediatr Urol. 2017;13(4):358–64.
Article CAS PubMed Google Scholar
Hird AE, et al. Association between chronic bladder catheterisation and bladder cancer incidence and mortality: a population-based retrospective cohort study in Ontario, Canada. BMJ Open. 2021;11(9):e050728.
Article PubMed PubMed Central Google Scholar
Kinnear N, et al. The impact of catheter-based bladder drainage method on urinary tract infection risk in spinal cord injury and neurogenic bladder: a systematic review. Neurourol Urodyn. 2020;39(2):854–62.
Soergel TM, et al. Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol. 2004;172(4 Pt 2):1649–51. discussion 1651-2
West DA, et al. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury. Urology. 1999;53(2):292–7.
Article CAS PubMed Google Scholar
Anderson JA, et al. Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study. Pathology. 2021;53(2):214–9.
Malone MJ, Izes JK, Hurley LJ, Carcinogenesis. The fate of intestinal segments used in urinary reconstruction. Urol Clin North Am. 1997;24(4):723–8.
Article CAS PubMed Google Scholar
Arlen AM, Dudley AG, Kieran K. Association of spina bifida with cancer. Transl Androl Urol. 2020;9(5):2358–69.
Article PubMed PubMed Central Google Scholar
Liu B, Welk B. Urological malignancies in neurogenic patients. Curr Opin Urol. 2020;30(4):501–6.
Article CAS PubMed Google Scholar
Rove KO, et al. Systematic review of bladder cancer outcomes in patients with spina bifida. J Pediatr Urol. 2017;13(5):456 e1–9.
Higuchi TT, Fox JA, Husmann DA. Annual endoscopy and urine cytology for the surveillance of bladder tumors after enterocystoplasty for congenital bladder anomalies. J Urol. 2011;186(5):1791–5.
Yang CC, Clowers DE. Screening cystoscopy in chronically catheterized spinal cord injury patients. Spinal Cord. 1999;37(3):204–7.
Article CAS PubMed Google Scholar
Hamid R, et al. Screening cystoscopy and biopsy in patients with neuropathic bladder and chronic suprapubic indwelling catheters: is it valid? J Urol. 2003;170(2 Pt 1):425–7.
Article CAS PubMed Google Scholar
Keenan A, et al. Long-term outcomes following bladder augmentation in children with neurogenic bladder. Curr Bladder Dysfunct Rep. 2014;9:275–81.
•• Sbizzera M, et al. Bladder cancer detection in patients with neurogenic bladder: are cystoscopy and cytology effective, and are biomarkers pertinent as future diagnostic tools? A scoping review. World J Urol. 2022;40(8):1897–913. This paper thoroughly explores the options for detecting and diagnosing bladder cancer in patients with neurogenic bladder and augmentation, something that is at the core of our review article.
Comments (0)